Boehringer Ingelheim acquires Pharmaxis' phase 1 anti-inflammatory drug …

Boehringer Ingelheim acquires Pharmaxis' phase 1 anti-inflammatory drug …

In this Jan. 29, 2014 file photo Joseph Jimenez, CEO of drug maker FRENCHS FOREST, Australia & INGELHEIM, Germany–(BUSINESS WIRE)–May 18, 2015–Boehringer Ingelheim and pharmaceutical company Pharmaxis announce that Boehringer …

(Visited 2 times, 1 visits today)
11
Like
Save

Comments

Comments are disabled for this post.